Silo Pharma
SILO
14 hedge funds and large institutions have $1.07M invested in Silo Pharma in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
884% more capital inflows, than outflows
Capital inflows: $854K | Capital outflows: $86.7K
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
8% more funds holding
Funds holding: 13 → 14 (+1)
2.57% more ownership
Funds ownership: 9.07% → 11.65% (+2.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Anson Funds Management
Dallas,
Texas
|
+$635K |
| 2 |
AdvisorShares Investments
Bethesda,
Maryland
|
+$120K |
| 3 |
Virtu Financial
New York
|
+$71.9K |
| 4 |
Jane Street
New York
|
+$11.2K |
| 5 |
StoneX Group
New York
|
+$8.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ursa Fund Management
Danville,
California
|
-$23.6K |
| 2 |
Two Sigma Securities
New York
|
-$17.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$17.7K |
| 4 |
XTX Topco
George Town,
Cayman Islands
|
-$16.9K |
| 5 |
Citigroup
New York
|
-$6.85K |
SILO Hedge Fund Activity: Q3 2025 in Review
14 of the 7,658 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q3 2025, worth a combined $1.07M — up 317% from $256K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SILO positions and 5 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $635K. The largest seller was Ursa Fund Management, exiting entirely with an estimated $23.6K sold.
- 14 institutional investors held Silo Pharma (SILO) as of Q3 2025, up from 13 in Q2 2025.
- Funds reported $1.07M of Silo Pharma stock for Q3 2025, up 317% quarter-over-quarter.
- 6 funds opened new Silo Pharma positions in Q3 2025 and 5 closed out, a net change of +1 holder.
- The largest Silo Pharma buyer in Q3 2025 was Anson Funds Management, an estimated $635K added.
- The largest Silo Pharma seller in Q3 2025 was Ursa Fund Management, an estimated $23.6K sold.
Based on aggregated 13F filings for Q3 2025.